We are live on
!
Find out more
RXII
GALENA BIOPHARMA INC COM
RXII
RXII
Delisted
RXII was delisted on the 25th of October, 2011.
71 hedge funds and large institutions have $36.5M invested in GALENA BIOPHARMA INC COM in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 34 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,187% more call options, than puts
Call options by funds: $8.5M | Put options by funds: $661K
209% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 11
8% less capital invested
Capital invested by funds: $39.7M → $36.5M (-$3.19M)
14% less funds holding
Funds holding: 83 → 71 (-12)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Holders
71
Holders Change
-12
Holders Change %
-14.46%
% of All Funds
1.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
34
Reduced
11
Closed
16
Calls
$8.5M
Puts
$661K
Net Calls
+$7.84M
Net Calls Change
+$6.24M
Top Buyers
Top Sellers
| 1 |
Group One Trading
Chicago,
Illinois
|
-$1.98M |
| 2 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$179K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$61.6K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$46.7K |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$44.1K |
